Emil Kakkis
Founder presso ULTRAGENYX PHARMACEUTICAL INC.
Patrimonio netto: 132 M $ in data 31/03/2024
Profilo
Emil D. Kakkis ha fondato Ultragenyx Pharmaceutical, Inc. e Everylife Foundation for Rare Diseases. Il Dr. Kakkis occupa la posizione di presidente, amministratore delegato e direttore di Ultragenyx Pharmaceutical, Inc. Il Dr. Kakkis è anche nel consiglio di Emil Kakkis & Jenny Soriano Living Trust e Odylia Therapeutics e presidente della Everylife Foundation for Rare Diseases. Nella sua carriera passata il Dr. Kakkis è stato Chief Medical Officer e Senior Vice President per BioMarin Pharmaceutical, Inc. e Assistant Professor all'Harbor-UCLA Medical Center. Il Dr. Kakkis ha conseguito una laurea al Pomona College e un dottorato alla David Geffen School of Medicine.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 01/03/2024 | 2 827 898 ( 3.43% ) | 132 M $ | 31/03/2024 |
Posizioni attive di Emil Kakkis
| Società | Posizione | Inizio |
|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Founder | 22/04/2010 |
| Emil Kakkis & Jenny Soriano Living Trust | Director/Board Member | - |
Everylife Foundation for Rare Diseases
 Everylife Foundation for Rare Diseases Miscellaneous Commercial ServicesCommercial Services EveryLife Foundation for Rare Diseases is a non-profit organization that aims to advance the development of treatment and diagnostic opportunities for rare disease patients through science-driven public policy. The non-profit company is based in Novato, CA and was founded by Emil D. Kakkis. The foundation provides training, education, resources, and opportunities to make patient voices heard, with the belief that activating the patient advocate can change public policy and save lives. | Founder | 01/03/2009 |
| Odylia Therapeutics | Director/Board Member | 01/01/2019 |
Precedenti posizioni note di Emil Kakkis
| Società | Posizione | Fine |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Chief Tech/Sci/R&D Officer | 27/02/2009 |
Harbor-UCLA Medical Center
 Harbor-UCLA Medical Center Medical/Nursing ServicesHealth Services Harbor-UCLA Medical Center provides medical practice, education, and research services. The private company is based in Torrance, CA. | Corporate Officer/Principal | 01/01/1998 |
Formazione di Emil Kakkis
| Pomona College | Undergraduate Degree |
| David Geffen School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Harbor-UCLA Medical Center
Harbor-UCLA Medical Center Medical/Nursing ServicesHealth Services Harbor-UCLA Medical Center provides medical practice, education, and research services. The private company is based in Torrance, CA. | Health Services |
| Emil Kakkis & Jenny Soriano Living Trust | |
Everylife Foundation for Rare Diseases
Everylife Foundation for Rare Diseases Miscellaneous Commercial ServicesCommercial Services EveryLife Foundation for Rare Diseases is a non-profit organization that aims to advance the development of treatment and diagnostic opportunities for rare disease patients through science-driven public policy. The non-profit company is based in Novato, CA and was founded by Emil D. Kakkis. The foundation provides training, education, resources, and opportunities to make patient voices heard, with the belief that activating the patient advocate can change public policy and save lives. | Commercial Services |
| Odylia Therapeutics |
- Borsa valori
- Insiders
- Emil Kakkis
